J 2010

microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients

HEŽOVÁ, Renata; Ondřej SLABÝ; Petra FALTEJSKOVÁ; Zuzana MIKULKOVÁ; Ivana BUREŠOVÁ et. al.

Základní údaje

Originální název

microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients

Název česky

microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients

Autoři

HEŽOVÁ, Renata (203 Česká republika); Ondřej SLABÝ (203 Česká republika, garant); Petra FALTEJSKOVÁ (203 Česká republika); Zuzana MIKULKOVÁ (203 Česká republika); Ivana BUREŠOVÁ (203 Česká republika); Karthick Raja MUTHU RAJA (356 Indie); Jan HODEK (203 Česká republika); Jaroslava OVESNÁ (203 Česká republika) a Jaroslav MICHÁLEK (203 Česká republika)

Vydání

Cellular Immunology, Elsevier, 2010, 0008-8749

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.575

Kód RIV

RIV/00216224:14110/10:00040729

Organizační jednotka

Lékařská fakulta

UT WoS

000273594200003

Klíčová slova anglicky

microRNA; Expression profile; Regulatory T cells; Diabetes mellitus type 1

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 4. 8. 2010 13:19, prof. RNDr. Ondřej Slabý, Ph.D.

Anotace

V originále

We performed miRNAs profiling in a population of regulatory T celss (Tregs) separated from peripheral blood of five type 1 diabetic patients and six healthy donors. For more detailed molecular char- acterisation of Tregs, we additionally compared miRNAs expression profiles of Tregs and conventional T cells. Tregs were isolated according to CD3+, CD4+, CD25hi+ and CD127low by flow cytometry, and miRNA expression profiling was performed using TaqMan Array Human MicroRNA Panel-1 (384-well low density array). In Tregs of diabetic patients we found significantly increased expression of miRNA-510 (p = 0.05) and decreased expression of both miRNA-342 (p< 0.0001) and miRNA-191 (p = 0.0079). When comparing Tregs and T cells, we revealed that Tregs had significant higher expression of miRNA-146a and lower expression of eight specific miRNAs (20b, 31, 99a, 100, 125b, 151, 335, and 365). This is the first study demonstrating changes in miRNA expression profiles occurring in Tregs of T1D patients and a miRNAs signature of adult Tregs.

Česky

We performed miRNAs profiling in a population of regulatory T celss (Tregs) separated from peripheral blood of five type 1 diabetic patients and six healthy donors. For more detailed molecular char- acterisation of Tregs, we additionally compared miRNAs expression profiles of Tregs and conventional T cells. Tregs were isolated according to CD3+, CD4+, CD25hi+ and CD127low by flow cytometry, and miRNA expression profiling was performed using TaqMan Array Human MicroRNA Panel-1 (384-well low density array). In Tregs of diabetic patients we found significantly increased expression of miRNA-510 (p = 0.05) and decreased expression of both miRNA-342 (p< 0.0001) and miRNA-191 (p = 0.0079). When comparing Tregs and T cells, we revealed that Tregs had significant higher expression of miRNA-146a and lower expression of eight specific miRNAs (20b, 31, 99a, 100, 125b, 151, 335, and 365). This is the first study demonstrating changes in miRNA expression profiles occurring in Tregs of T1D patients and a miRNAs signature of adult Tregs.

Návaznosti

NR9355, projekt VaV
Název: Imunoregulační funkce u dětských pacientů s diabetes mellitus
2B08066, projekt VaV
Název: Studium léčebných možností diabetes mellitus 1. typu jako geneticky determinované metabolické choroby s využitím nových imunoterapeutických postupů